IL6 and breast cancer: Other studies have reported that high serum levels of circulating IL-6 negatively impact the RFS and are associated with poor prognosis in patients with breast cancer.28,29 Taken together, further studies are warranted to understand the complexity of the mechanism by which enriched adipose tissue affects the genomic profiles of young patients with ER+ breast cancer with obesity.